News
Aortic valve narrowing (aortic stenosis) with concomitant cardiac amyloidosis is a severe heart disease of old age that is ...
1d
News-Medical.Net on MSNDual treatment strategy offers survival advantage for patients with severe heart diseaseAortic valve narrowing (aortic stenosis) with concomitant cardiac amyloidosis is a severe heart disease of old age that is ...
9h
MedPage Today on MSNTAVR System Dropped; Treprostinil Powder Approved; Post-MI CancerThe FDA approved treprostinil (Yutrepia) inhalation powder for pulmonary arterial hypertension and pulmonary hypertension ...
The Peter Munk Centre for Excellence in Aortic Disease is on the cutting edge of aortic care and research. The same team is ...
Boston Scientific ends global sales of ACURATE valves and halts FDA pursuit, citing rising regulatory burdens; expects to ...
In a first for Nagpur, a remarkable milestone in cardiac care was achieved as three transcatheter aortic valve implantation ...
Once again, data are suggesting that operators should move cautiously in bicuspid anatomy and think about surgery first.
Boston Scientific is pulling its latest transcatheter aortic heart valve platform from the worldwide market and said it will ...
Edwards Lifesciences (EW) stock and Medtronic (MDT) stock gain as Boston Scientific (BSX) halts sales of ACURATE heart valves ...
The humble toilet seems like the least likely setting for drama. Yet throughout history, it has claimed kings, toppled ...
According to the study’s abstract in The Lancet, TAVR with Acurate neo2 failed to meet non-inferiority. It also resulted in ...
Boston Scientific (NYSE: BSX) today shared real-world clinical data backing its Acurate Prime aortic valve system.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results